Product Information
VENLAFAXINE HCL ER 225 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.5160 per EA under NDC 70710135209. Its NADAC has been published 182 times since Jan 4, 2023.
Strength
225 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710135209
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215622On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 225 MG TAB has been published 182 times since Jan 4, 2023, and over the history we have for it it has declined 75.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5160 per EA |
|---|---|
| All-time high | $2.0854 (Jan 11, 2023) |
| All-time low | $0.4592 (Nov 20, 2024) |
| 52-week high | $0.6923 |
| 52-week low | $0.4955 |
| Median price | $0.6846 |
| Average price | $0.7928 |
| Largest weekly change | +54.1% (Feb 22, 2023) |
| Weeks tracked | 182 |
| Tracking since | Jan 4, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 225 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 225 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.5160 per EA (NDC 70710135209), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 225 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has declined 75.3%. It has been tracked across 182 weekly CMS publications since Jan 4, 2023.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 225 MG TAB?
Since Jan 4, 2023, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has ranged from a low of $0.4592 (Nov 20, 2024) to a high of $2.0854 (Jan 11, 2023), with a median of $0.6846 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 225 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 225 MG TAB, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 225 MG TAB?
VENLAFAXINE HCL ER 225 MG TAB (NDC 70710135209) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification